These drugs, called checkpoint inhibitors, have been approved by the Food and drug Administration to treat advanced melanoma, Hodgkin lymphoma and cancers of the lung, kidney and bladder.
2
目的：评价介入治疗晚期膀胱癌的疗效。
Objective To evaluate the effects of interventional therapy for advanced bladder cancer.
点击反馈